Dr. Alpaslan Dedeoglu received his MD from the Istanbul University School of Medicine and completed a pharmacology program at the Marmara University in 1992.\u00a0 During and after his pharmacology program he worked at the University of Arizona, Ohio State University, and Massachusetts General Hospital; he then joined Boston University in 2000.\u00a0 Dr. Dedeoglu\u2019s major research interests are neuroanatomy, neuropathology, and the neurochemistry of animal models of neurodegenerative disorders.\u00a0 His labs are located at the Boston VA Medical Center.\u00a0 Dr. Dedeoglu is the PI of several ongoing projects that are funded by\u00a0the NIH, VA, and private foundations.<\/p>\n
Dr. Dedeoglu\u2019s research interests include the following: neuroanatomy, immunocytochemistry, histochemistry of the brain, neuropathological and neurochemical basis of neurological disorders, and animal models of neurological diseases. He also works with therapeutic trials in rodent models of neurodegenerative disorders.<\/p>\n
Dr. Dedeoglu has received various awards:\u00a0Sandoz Pharmacology Science Award (1989),\u00a0Eczacibasi Scientific Research and Medicine Encouragement Award (1992), Alzheimer\u2019s Disease Core Center pilot award (2001-2002). \u201cTherapeutic Strategies in a Mouse Model of AD\u201d\u00a0\u00a0Principal Investigator, Alzheimer\u2019s Association New Investigator Award (2002-2004)\u201d Anti-inflammatory Therapy in a Mouse Model of AD\u201c\u00a0\u00a0Principal Investigator, Merit Award (2004-2011) \u201cTherapeutic Strategies in a Transgenic Model of AD\u201d,\u00a0Principal Investigator, R21 NIA (2005-2007), Integrated Neuroimaging and Pathology of Alzheimer Mice\u201d,\u00a0Principal Investigator, Merit Award (2005-2008) \u201cIntegrated neuroimaging and neuropathological study of exercise in ALS\u201d<\/p>\n
Dr. Dedeoglu is a member of the Boston Society of Neurology and Psychiatry and the Society for Neuroscience.<\/p>\n